Avadel Pharmaceuticals
8.03
0.21 (2.69%)
At close: Jan 14, 2025, 3:59 PM
8.37
4.30%
After-hours Jan 14, 2025, 07:55 PM EST

Avadel Pharmaceuticals Revenue Breakdown

Quarter Jun 30, 2020Mar 31, 2020Sep 30, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018Jun 30, 2018Mar 31, 2018Sep 30, 2017Jun 30, 2017Mar 31, 2017Sep 30, 2016Jun 30, 2016Mar 31, 2016
Akovaz Revenue 4.20M 5.35M 4.21M 5.95M 3.79M 5.99M 11.88M 10.22M 18.56M 20.91M 25.64M 5.57M 25.62M 24.75M
Akovaz Revenue Growth -21.56% +27.12% -29.23% +56.80% -36.71% -49.55% +16.23% -44.95% -11.24% -18.43% +360.45% -78.27% +3.53% n/a
Bloxiverz Revenue 800.00K 1.40M 1.47M 2.36M 2.57M 3.66M 5.54M 7.49M 9.92M 13.72M 13.90M 15.59M 2.12M 1.20M
Bloxiverz Revenue Growth -42.90% -4.43% -37.83% -8.18% -29.76% -34.05% -25.99% -24.49% -27.69% -1.32% -10.83% +634.04% +77.00% n/a
Other Products Revenue 180.00K -21.00K -231.00K -160.00K 604.00K 373.00K 31.00K 1.83M 1.09M 2.32M 2.04M 841.00K 10.42M 9.41M
Other Products Revenue Growth -957.14% -90.91% +44.38% -126.49% +61.93% +1103.23% -98.30% +67.06% -52.89% +13.84% +142.33% -91.93% +10.79% n/a
Vazculep Revenue 4.92M 5.51M 8.79M 9.41M 9.47M 8.76M 11.38M 12.96M 9.57M 10.15M 10.18M 9.34M n/a n/a
Vazculep Revenue Growth -10.86% -37.24% -6.63% -0.67% +8.15% -23.01% -12.22% +35.39% -5.72% -0.25% +8.98% n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015
Ireland Revenue n/a n/a 1.85M 404.00K 2.96M 741.00K
Ireland Revenue Growth n/a -100.00% +356.93% -86.37% +299.87% n/a
United States Revenue 22.33M 59.22M n/a 172.84M 147.28M 172.38M
United States Revenue Growth -62.28% n/a n/a +17.35% -14.56% n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 40.39M 47.41M 48.62M 41.30M 39.16M 46.78M 24.47M 16.98M 14.10M 21.80M 21.64M 21.03M 21.28M 15.17M 11.01M 8.97M 8.42M 7.09M 7.91M 7.66M 5.32M 6.76M 10.45M 23.20M 24.83M 27.84M 24.49M 23.06M 11.56M 12.43M 11.81M 10.69M 12.74M 11.29M 9.46M 6.81M 4.57M 5.87M 4.46M
Selling, General, and Administrative Revenue Growth -14.79% -2.50% +17.73% +5.47% -16.29% +91.18% +44.09% +20.47% -35.35% +0.78% +2.90% -1.21% +40.26% +37.80% +22.71% +6.54% +18.72% -10.34% +3.26% +44.15% -21.34% -35.31% -54.97% -6.56% -10.82% +13.71% +6.20% +99.41% -6.97% +5.22% +10.52% -16.11% +12.84% +19.33% +38.97% +49.04% -22.22% +31.59% n/a
Research and Development Revenue 3.80M 4.05M 3.07M 2.36M 2.85M 4.22M 3.83M 6.24M 2.93M 4.54M 6.99M 2.11M 4.38M 6.76M 3.85M 5.29M 5.57M 4.06M 5.53M 7.76M 7.54M 10.29M 7.33M 6.09M 11.40M 11.89M 9.95M 12.13M 8.10M 6.79M 7.21M 13.48M 8.14M 7.60M 5.39M 5.16M 7.22M 7.20M 6.02M
Research and Development Revenue Growth -6.12% +32.04% +30.06% -17.20% -32.54% +10.26% -38.57% +112.58% -35.41% -35.05% +231.33% -51.83% -35.23% +75.55% -27.13% -5.08% +37.27% -26.64% -28.71% +2.89% -26.75% +40.43% +20.42% -46.62% -4.10% +19.49% -17.93% +49.78% +19.18% -5.75% -46.53% +65.49% +7.09% +41.13% +4.40% -28.53% +0.24% +19.63% n/a

Create Price Alert on AVDL

Your price alert will notify you when the stock price is above 8.03.

Add to Watchlist